GTC
FUSN

Ghost Tree Capital’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Ghost Tree Capital’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-243,287
Closed -$633K – 81
2023
Q3 		$633K Sell
243,287
-169,412
-41% -$543K 0.21% 64
2023
Q2 		$1.93M Buy
412,699
+62,699
+18% +$271K 0.64% 37
2023
Q1 		$1.32M Buy
+350,000
New +$1.38M 0.39% 48

Other funds holding FUSN

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Ghost Tree Capital's FUSN Position: Q4 2023 in Review

Ghost Tree Capital sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q4 2023, closing a stake of 243,287 shares — an estimated $633K sold.

Ghost Tree Capital first reported a position in FUSN in Q1 2023 and held it in 3 quarters. The position peaked at $1.93M in Q2 2023. 77 funds tracked by Wall St. Rank hold FUSN as of Q4 2023.

  • Ghost Tree Capital reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q4 2023 after selling out during the quarter.
  • Ghost Tree Capital sold 243,287 Fusion Pharmaceuticals Inc. Common Shares shares in Q4 2023, an estimated $633K.
  • Ghost Tree Capital first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2023 and held it in 3 quarters.
  • Ghost Tree Capital's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.93M in Q2 2023.
  • 77 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q4 2023.

Based on Ghost Tree Capital's 13F filing for Q4 2023, filed 14 Feb 2024.